Anticentromere antibodies in primary biliary cirrhosis
1983; Wiley; Volume: 26; Issue: 7 Linguagem: Inglês
10.1002/art.1780260714
ISSN1529-0131
AutoresDrew Makinen, Marvin J. Fritzler, Paul J. Davis, Sheila Sherlock,
Tópico(s)Systemic Lupus Erythematosus Research
ResumoArthritis & RheumatismVolume 26, Issue 7 p. 914-917 Brief ReportFree to Read Anticentromere antibodies in primary biliary cirrhosis Drew Makinen MD, Drew Makinen MD Medical Resident Departments of Medicine, University of Alberta and University of Calgary, Canada and The Royal Free Hospital, London, England.Search for more papers by this authorMarvin Fritzler PhD, MD, Marvin Fritzler PhD, MD Associate Professor Of Medicine Departments of Medicine, University of Alberta and University of Calgary, Canada and The Royal Free Hospital, London, England.Search for more papers by this authorDr Paul Davis MD, Corresponding Author Dr Paul Davis MD Associate Professor Of Medicine Departments of Medicine, University of Alberta and University of Calgary, Canada and The Royal Free Hospital, London, England.9-112 Clinical Sciences Building, University of Alberta, Edmonton, Alberta, CanadaSearch for more papers by this authorSheila Sherlock MD, Sheila Sherlock MD Professor Of Medicine Departments of Medicine, University of Alberta and University of Calgary, Canada and The Royal Free Hospital, London, England.Search for more papers by this author Drew Makinen MD, Drew Makinen MD Medical Resident Departments of Medicine, University of Alberta and University of Calgary, Canada and The Royal Free Hospital, London, England.Search for more papers by this authorMarvin Fritzler PhD, MD, Marvin Fritzler PhD, MD Associate Professor Of Medicine Departments of Medicine, University of Alberta and University of Calgary, Canada and The Royal Free Hospital, London, England.Search for more papers by this authorDr Paul Davis MD, Corresponding Author Dr Paul Davis MD Associate Professor Of Medicine Departments of Medicine, University of Alberta and University of Calgary, Canada and The Royal Free Hospital, London, England.9-112 Clinical Sciences Building, University of Alberta, Edmonton, Alberta, CanadaSearch for more papers by this authorSheila Sherlock MD, Sheila Sherlock MD Professor Of Medicine Departments of Medicine, University of Alberta and University of Calgary, Canada and The Royal Free Hospital, London, England.Search for more papers by this author First published: July 1983 https://doi.org/10.1002/art.1780260714Citations: 72AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat References 1 Sharp GC, Irvin WC, Tan EM, Gould RG, Holman HR: Mixed connective tissue disease: an apparently distinct rheumatic disease syndrome associated with a specific antibody to an extractable nuclear antigen (ENA). Am J Med 52: 148–159, 1972 2 Davis P, Makinen DR: Antibody to synthetic poly dAT: correlation with antibody to native DNA and specificity for SLE. J Clin Pathol 33: 648–652, 1980 3 Martinez-Lavin M, Vaughan JH, Tan EM: Autoantibodies and the spectrum of Sjogren's syndrome. Ann Intern Med 91: 185–190, 1979 4 Tan EM, Rodnan GP, Garcia I, Moroi Y, Fritzler MJ, Peebles C: Diversity of antinuclear antibodies in progresive systemic sclerosis: anti-centromere antibody and its relationship to CREST syndrome. Arthritis Rheum 23: 617–625, 1980 5 Fritzler MJ, Kinsella TD: The CREST syndrome: a distinct serologic entity with anticentromere antibodies. Am J Med 69: 520–526, 1980 6 Uhl GS, Baldwin JL, Arnett FC: Primary biliary cirrhosis in systemic sclerosis (scleroderma) and polymyositis. Johns Hopkins Med J 135: 191–198, 1974 7 Murray-Lyon IM, Thompson RPH, Ansell ID, Williams R: Scleroderma and primary biliary cirrhosis. Br Med J 3: 258–259, 1970 8 Reynolds TB, Denison EK, Frankl HD, Lieverman FL, Peters RL: Primary biliary cirrhosis with scleroderma, Raynaud's phenomenon and telangiectasia. Am J Med 50: 302–312, 1971 9 August PJ: Primary biliary cirrhosis and scleroderma. Proc R Soc Med 67: 58, 1974 10 Clarke AK, Galbraith RM, Hamilton EBD, Williams R: Rheumatic disorders in primary biliary cirrhosis. Ann Rheum Dis 37: 42–47, 1978 11 Sherlock S, Scheuer PJ: The presentation and diagnosis of 100 patients with primary biliary cirrhosis. New Eng J Med 290: 674–678, 1973 12 Sherlock S: Chronic hepatitis. Gut 15: 581–597, 1974 13 Chapman RWG, Arborgh BAM, Rhodes JM, Summer-field JA, Dick R, Scheuer PJ, Sherlock S: Primary sclerosing cholangitis: a review of its clinical features, cholangiography and hepatic histology. Gut 21: 870–877, 1980 14 Moroi Y, Peebles C, Fritzler M, Steigerwald J, Tan EM: Autoantibody to centromere (kinetochore) in scleroderma sera. Proc Natl Acad Sci USA 77: 1627–1631, 1980 15 Bernstein RM, Callender ME, Neuberger JM, Hughes GRV, Williams R: Anticentromere antibody in primary biliary cirrhosis. Ann Rheum Dis 41: 612–614, 1982 Citing Literature Volume26, Issue7July 1983Pages 914-917 ReferencesRelatedInformation
Referência(s)